Mallinckrodt to acquire Sucampo Pharmaceuticals for $1.2B. The cash tender offer equates to $18 per share.
Mallinckrodt to take ownership of Amitiza, a leading medicine servicing the branded constipation market (as well as other molecules for the orphan diseases niche).
This is an abbreviated version of the in-depth Integrated BioSci Report available in advance to our marketplace subscribers.
READ FULL ARTICLE HERE
David S. Brown Enterprises has bolstered its Retail Leasing team with the recent hiring of Michael Gosnell
The Virginia law firm Gentry Locke is pleased to announce the promotion of Scott A. Stephenson to
Pessin Katz Law is pleased to announce that Attorney Adam E. Konstas has been elected to Member
Skanska, a leading global construction and development firm, announces that Gary Orton has joined the company as
For partnerships, content marketing or advertising inquiries, please contact Edwin through his LinkedIn Profile
Connect© Copyright 2024 citybuzz
